塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/31 | 7,594 | 7,650 | 7,530 | 7,530 | -33 | -0.4% | 1,592,600 |
2022/03/30 | 7,685 | 7,724 | 7,484 | 7,563 | -161 | -2.1% | 1,593,200 |
2022/03/29 | 7,795 | 7,827 | 7,644 | 7,724 | -126 | -1.6% | 1,693,800 |
2022/03/28 | 7,755 | 7,897 | 7,730 | 7,850 | -54 | -0.7% | 1,645,400 |
2022/03/25 | 7,580 | 7,955 | 7,524 | 7,904 | +340 | +4.5% | 3,986,400 |
2022/03/24 | 7,420 | 7,564 | 7,307 | 7,564 | +19 | +0.3% | 1,446,500 |
2022/03/23 | 7,501 | 7,583 | 7,465 | 7,545 | +80 | +1.1% | 1,448,000 |
2022/03/22 | 7,500 | 7,514 | 7,393 | 7,465 | -7 | -0.1% | 1,442,300 |
2022/03/18 | 7,473 | 7,492 | 7,330 | 7,472 | -38 | -0.5% | 1,724,400 |
2022/03/17 | 7,430 | 7,538 | 7,393 | 7,510 | +272 | +3.8% | 1,933,800 |
2022/03/16 | 7,071 | 7,322 | 7,067 | 7,238 | +170 | +2.4% | 1,890,000 |
2022/03/15 | 6,826 | 7,115 | 6,752 | 7,068 | +231 | +3.4% | 2,177,800 |
2022/03/14 | 7,046 | 7,060 | 6,616 | 6,837 | -174 | -2.5% | 2,759,100 |
2022/03/11 | 7,159 | 7,159 | 6,973 | 7,011 | -223 | -3.1% | 2,253,400 |
2022/03/10 | 7,167 | 7,265 | 7,122 | 7,234 | +125 | +1.8% | 2,394,000 |
2022/03/09 | 7,212 | 7,241 | 6,977 | 7,109 | -68 | -0.9% | 2,612,800 |
2022/03/08 | 7,781 | 7,817 | 7,152 | 7,177 | -671 | -8.5% | 4,097,500 |
2022/03/07 | 7,800 | 8,019 | 7,782 | 7,848 | +133 | +1.7% | 3,058,700 |
2022/03/04 | 7,835 | 7,840 | 7,601 | 7,715 | -84 | -1.1% | 1,893,200 |
2022/03/03 | 7,800 | 7,831 | 7,755 | 7,799 | +22 | +0.3% | 1,315,300 |
2022/03/02 | 7,714 | 7,777 | 7,682 | 7,777 | -16 | -0.2% | 1,256,800 |
2022/03/01 | 7,735 | 7,829 | 7,720 | 7,793 | +152 | +2% | 2,074,200 |
2022/02/28 | 7,599 | 7,646 | 7,434 | 7,641 | +28 | +0.4% | 2,908,500 |
2022/02/25 | 7,483 | 7,840 | 7,405 | 7,613 | +130 | +1.7% | 5,754,900 |
2022/02/24 | 7,390 | 7,502 | 7,365 | 7,483 | +45 | +0.6% | 1,509,500 |
2022/02/22 | 7,501 | 7,543 | 7,366 | 7,438 | -147 | -1.9% | 1,456,700 |
2022/02/21 | 7,531 | 7,650 | 7,351 | 7,585 | -96 | -1.2% | 1,127,600 |
2022/02/18 | 7,543 | 7,722 | 7,526 | 7,681 | +47 | +0.6% | 1,392,400 |
2022/02/17 | 7,615 | 7,669 | 7,551 | 7,634 | -11 | -0.1% | 1,292,500 |
2022/02/16 | 7,695 | 7,729 | 7,583 | 7,645 | +42 | +0.6% | 1,837,300 |
2022/02/15 | 7,765 | 7,798 | 7,580 | 7,603 | -166 | -2.1% | 1,986,600 |
2022/02/14 | 7,720 | 7,828 | 7,638 | 7,769 | -98 | -1.2% | 1,923,100 |
2022/02/10 | 7,829 | 7,920 | 7,759 | 7,867 | ±0 | ±0% | 2,159,400 |
2022/02/09 | 7,620 | 7,893 | 7,603 | 7,867 | +3 | ±0% | 3,739,100 |
2022/02/08 | 8,209 | 8,350 | 7,834 | 7,864 | -120 | -1.5% | 7,797,000 |
2022/02/07 | 7,919 | 8,039 | 7,858 | 7,984 | +230 | +3% | 3,624,800 |
2022/02/04 | 7,900 | 8,029 | 7,567 | 7,754 | -170 | -2.1% | 5,268,800 |
2022/02/03 | 7,411 | 8,000 | 7,409 | 7,924 | +363 | +4.8% | 5,227,200 |
2022/02/02 | 7,152 | 7,720 | 7,117 | 7,561 | +470 | +6.6% | 6,642,000 |
2022/02/01 | 7,177 | 7,177 | 6,837 | 7,091 | +664 | +10.3% | 4,968,500 |
2022/01/31 | 6,428 | 6,464 | 6,325 | 6,427 | +112 | +1.8% | 1,616,600 |
2022/01/28 | 6,290 | 6,390 | 6,195 | 6,315 | +165 | +2.7% | 2,052,000 |
2022/01/27 | 6,453 | 6,453 | 6,119 | 6,150 | -247 | -3.9% | 2,817,800 |
2022/01/26 | 6,666 | 6,683 | 6,333 | 6,397 | -392 | -5.8% | 3,129,000 |
2022/01/25 | 6,915 | 6,960 | 6,746 | 6,789 | -121 | -1.8% | 1,621,100 |
2022/01/24 | 6,856 | 6,912 | 6,727 | 6,910 | -31 | -0.4% | 1,707,000 |
2022/01/21 | 7,020 | 7,063 | 6,880 | 6,941 | -59 | -0.8% | 2,250,600 |
2022/01/20 | 7,023 | 7,114 | 6,931 | 7,000 | -118 | -1.7% | 1,801,600 |
2022/01/19 | 7,279 | 7,289 | 7,085 | 7,118 | -270 | -3.7% | 1,888,400 |
2022/01/18 | 7,525 | 7,553 | 7,375 | 7,388 | -92 | -1.2% | 1,206,700 |
651~
700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム